Retinoic acid suppresses growth of lesions, inhibits peritoneal cytokine secretion, and promotes macrophage differentiation in an immunocompetent mouse model of endometriosis
article
OA: closed
CC0
⤵ 53 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
Retinoic acid treatment in a mouse model of endometriosis reduced lesion growth, suppressed peritoneal cytokine release, and enhanced macrophage differentiation.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (67)
- Adult Physical Activity and Endometriosis Risk via openalex
- Advances in the genetics of endometriosis via openalex
- Altered Retinoid Uptake and Action Contributes to Cell Survival in Endometriosis via openalex
- Analysis of an interleukin-6 gene promoter polymorphism in women with endometriosis by pyrosequencing via openalex
- An experimental model for the endometriosis in athymic mice via openalex
- A prospective study of dietary fat consumption and endometriosis risk via openalex
- Cytokine profiles in serum and peritoneal fluid from infertile women with and without endometriosis via openalex
- Development of an experimental model of endometriosis using mice that ubiquitously express green fluorescent protein via openalex
- Downregulation of CD36 results in reduced phagocytic ability of peritoneal macrophages of women with endometriosis via openalex
- Endometrial ability to implant in ectopic sites can be prevented by interleukin-12 in a murine model of endometriosis via openalex
- Endometriosis via openalex
- Endometriosis expresses a molecular pattern consistent with decreased retinoid uptake, metabolism and action via openalex
- Immunobiology of endometriosis via openalex
- Increased interleukin-6 levels in peritoneal fluid of infertile patients with active endometriosis via openalex
- Induction of endometriosis in mice: A new model sensitive to estrogen via openalex
- Inhibition of CD36-Dependent Phagocytosis by Prostaglandin E2 Contributes to the Development of Endometriosis via openalex
- Interleukin-6 and other soluble factors in peritoneal fluid and endometriomas and their relation to pain and aromatase expression via openalex
- Macrophages Are Alternatively Activated in Patients with Endometriosis and Required for Growth and Vascularization of Lesions in a Mouse Model of Disease via openalex
- Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity via openalex
- Peritoneal Macrophages Induce RANTES (Regulated on Activation, Normal T Cell Expressed and Secreted) Chemokine Gene Transcription in Endometrial Stromal Cells via openalex
- Progestins inhibit expression of MMPs and of angiogenic factors in human ectopic endometrial lesions in a mouse model via openalex
- Retinoic acid suppresses interleukin-6 production in human endometrial cells via openalex
- Simvastatin Protects against the Development of Endometriosis in a Nude Mouse Model via openalex
- Steroid and Cytokine Regulation of Matrix Metalloproteinase Expression in Endometriosis and the Establishment of Experimental Endometriosis in Nude Mice via openalex
- The effects of ergot and non-ergot-derived dopamine agonists in an experimental mouse model of endometriosis via openalex
- The presence of endometrial cells in the peritoneal cavity enhances monocyte recruitment and induces inflammatory cytokines in mice: Implications for endometriosis via openalex
- The SCID mouse: an experimental model for endometriosis via openalex
- W2100496536 via openalex
- W2126982510 via openalex
- W2131261387 via openalex
- W2142053169 via openalex
- W2142851096 via openalex
- W2160836190 via openalex
- W2163215955 via openalex
- W2253736588 via openalex
- W2346020725 via openalex
- W2628053793 via openalex
- W4206003776 via openalex
- W4312615442 via openalex
- W54801374 via openalex
- W6665876517 via openalex
- W1487546854 via openalex
- W1524665767 via openalex
- W1526228971 via openalex
- W1538907359 via openalex
- W1964207984 via openalex
- W1971271779 via openalex
- W1977077509 via openalex
- W1979087586 via openalex
- W1979771779 via openalex
- W1998177490 via openalex
- W1998778584 via openalex
- W1998914453 via openalex
- W2002480640 via openalex
- W2003763285 via openalex
- W2017967258 via openalex
- W2018938924 via openalex
- W2026140728 via openalex
- W2028096241 via openalex
- W2039853192 via openalex
- W2041976368 via openalex
- W2044224359 via openalex
- W2048766815 via openalex
- W2080674179 via openalex
- W2090728162 via openalex
- W2091573707 via openalex
- W2100196548 via openalex
Cited by (50)
- Biomaterial Tools for Modeling Endometriosis 2026
- Transgenic mice applications in the study of endometriosis pathogenesis 2024
- Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Additional file 2 of Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Additional file 6 of Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Additional file 3 of Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Retinoic acid receptor alpha expression in endometrioid heterotopias and the endometrium of patients with endometriosis 2024
- Additional file 4 of Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Additional file 1 of Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Additional file 6 of Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Additional file 5 of Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Additional file 4 of Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Additional file 5 of Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Additional file 1 of Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Additional file 2 of Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Additional file 3 of Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Whole exome sequencing reveals novel candidate variants for endometriosis utilizing multiple affected members in a single family 2023
- Retinoic acid action is altered within endometrium of baboons affected with endometriosis 2022
- Endometriosis-Associated Angiogenesis and Anti-angiogenic Therapy for Endometriosis 2022
- Endometriosis in the Mouse: Challenges and Progress Toward a ‘Best Fit’ Murine Model 2022
- Single‐cell Raman trapping analysis revealed immunometabolism changes in peritoneal fluid in endometriosis 2021
- Preclinical models of endometriosis and interstitial cystitis/bladder pain syndrome: an Innovative Medicines Initiative-PainCare initiative to improve their value for translational research in pelvic pain 2021
- G-CSF and IL-6 may be involved in formation of endometriosis lesions by increasing the expression of angiogenic factors in neutrophils 2021
- Role of medical treatment of endometriosis 2021
- All-trans retinoic acid inhibits epithelial-to-mesenchymal transition (EMT) through the down-regulation of IL-6 in endometriosis 2021
- Animal models for research on endometriosis 2020
- Interleukin-37b inhibits the growth of murine endometriosis-like lesions by regulating proliferation, invasion, angiogenesis and inflammation 2020
- Comparison of the effect of isotretionin and alitretionin on endometriotic implants and serum vascular endothelial growth factor level: an experimental study 2019
- Endometriosis and nuclear receptors 2019
- Exosome-mediated microRNA-138 and vascular endothelial growth factor in endometriosis through inflammation and apoptosis via the nuclear factor-κB signaling pathway 2018
- Active compounds present inRosmarinus officinalis leaves andScutellaria baicalensis root evaluated as new therapeutic agents for endometriosis 2018
- Current and emerging treatment options for endometriosis 2018
- Investigational drugs for the treatment of endometriosis, an update on recent developments 2018
- The use of retinoic acid for the treatment of endometriosis 2018
- Physiological and pathological implications of retinoid action in the endometrium 2018
- The neoangiogenesis in the development of endometriosis (a review) 2017
- The neoangiogenesis in the development of endometriosis (a review) 2017
- Retinoid Metabolism in Endometriosis 2017
- Exogenous activated NK cells enhance trafficking of endogenous NK cells to endometriotic lesions 2015
- An overview of early drug development for endometriosis 2015
- Retinoic acid has the potential to suppress endometriosis development 2015
- Non‐hormonal targets underlying endometriosis: A focus on molecular mechanisms 2015
- Pathogenesis of Endometriosis: Roles of Retinoids and Inflammatory Pathways 2015
- Retinoic Acid Biosynthesis Is Impaired in Human and Murine Endometriosis1 2014
- Novel agents for the medical treatment of endometriosis 2014
- Prevention of Endometriosis 2014
- Endometriosis in Experimental Models 2014
- Defining Future Directions for Endometriosis Research: Workshop Report From the 2011 World Congress of Endometriosis in Montpellier, France 2013
- Eutopic Endometrium in Women with Endometriosis: Ground Zero for the Study of Implantation Defects 2013
- The role of Lipoxin A4 in endometrial biology and endometriosis 2013
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:16:17.081435+00:00
License: CC0
· commercial use OK